The proposed no-premium, merger-of-equals combining CVS Corp. and Caremark Rx Inc. landed with a thud when it was announced November 1. The deal to "create a powerful force for change in pharmacy services" sparked a sell-off in shares of both companies. And that opened up an opportunity for Express Scripts Inc. to step in with a more straightforward $26 billion cash-and-stock takeover bid for Caremark, promising to create "the world’s preeminent pharmacy benefit management company."
The angst this tussle has generated in the distribution world has had little impact on drug companies. But there is...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?